IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eversept Partners, LP

Q4 2018 Holdings

Filed 2019-02-13 | 54 holdings | $184.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Abiomed Inc(ABMDEUR)ACOM003654100$4.5M13,9392.5%
Danaher Corp del(DHR)ACOM235851102$4.9M47,8042.7%
Vertex Pharmaceuticals Inc(VRTX)ACOM92532F100$6.0M36,4923.3%
Aerie Pharmaceuticals Inc(AERIEUR)ACOM00771V108$8.4M232,7904.6%
Radius Health IncACOM NEW750469207$9.1M552,0534.9%
Sanofi(SNY)ASPONSORED ADR80105N105$13.3M306,2427.2%
Amarin Corp PLCASPONS ADR NEW023111206$17.2M1,263,4079.3%
R1 RCM IncACOM749397105$18.7M2,349,30610.1%
Glaxosmithkline PLCASPONSORED ADR37733W105$20.4M529,48411.0%
Zogenix IncACOM NEW98978L204$20.5M563,42911.1%
PreviousPage 2 of 2